Products Cited in Publications Worldwide Development of reactive oxygen species (ROS) inhibitors and prodrugs for multiple applications

Development of reactive oxygen species (ROS) inhibitors and prodrugs for multiple applications

Senevirathne, Priyangika Prasadini

Abstract

Reactive oxygen species are a group of highly reactive oxygen-containing entities that are important at a cellular level for multiple biological processes. Low concentrations of ROS can be beneficial as powerful signaling molecules in those biological processes, although excessive concentrations can promote high levels of DNA damage and a variety of diseases such as skin cancer. A newly identified intracellular ROS production source in skin cells is NADPH oxidases. Out of the NOX enzyme family, the NOX1 holoenzyme is most abundantly expressed in the human keratinocyte cells. UV radiation can trigger the activation of NOX1 isoforms which stimulate the assembling of member CYBA and the cytoplasmic protein NOXO1. Inhibition of these enzymes represents a catalytic approach toward reducing ROS for the prevention of ROS inducible diseases. Key disease states include melanoma induced by UV exposure. The first half of the dissertation focuses on investigating new small molecule inhibitors of a key NOX1 holoenzyme to address these challenges. We designed a series of molecules by optimizing the structure of diapocynin and evaluated by in-silico docking methods to determine the binding affinity with NOXO1 cytoplasmic protein (1WLP crystal structure). And have synthesized the series of target molecules for the structure-activity relationship studies. In the first section of the project, we discovered that inhibitor NOX_inh_5 was not cytotoxic, but instead improved the viability of human primary cells from UV exposure, decreased the cellular stress in human skin through the p53 pathway, and reduced the UV-induced DNA damage as monitored by quantification of cyclobutane dimer formation after UV exposure. Then, we characterized the inhibition potential of NOX_inh_5 by using an Isothermal calorimetric (ITC) binding assay and heteronuclear single quantum coherence (HSQC) technique and revealed that the candidate iii molecule can prevent the complex formation of NOXO1 and CYBA membrane protein. In the second section of the project, we did a structure-activity relationship study for the NOX_inh_5 small molecule to optimize the biological characteristics. The last section of the dissertation discussed the development of ROS sensible prodrug to combat the opioid overdose crisis. Here we used oxidative stress conditions caused by opioid overdose to activate the prodrug. Even though opioid antagonist naloxone has a high affinity to bind with opioid receptors to block opioid-induced activation, it is metabolically unstable and has a short half-life of around 33 min. We developed a peroxide-induced prodrug to overcome this issue that can release a steady stream of naloxone. This allows the concentration of naloxone to remain high for longer periods.

Purchased from AmBeed

A1169121007-16-597%

3-Bromo-4-fluorobenzoic acid

10.0/10g

Detail
1,5-Dibromopentane

A154427111-24-099%

1,5-Dibromopentane

10.0/5g

Detail
Tetrakis(triphenylphosphine)palladium

A21139114221-01-398%

Tetrakis(triphenylphosphine)palladium

54.0/5g

Detail
Methyl 3-boronobenzoate

A22571399769-19-498%

Methyl 3-boronobenzoate

10.0/1g

Detail

A229957351422-73-697%

(3-Carbamoylphenyl)boronic acid

155.0/100g

Detail
1-Boc-4-bromomethylpiperidine

A238495158407-04-697%

1-Boc-4-bromomethylpiperidine

247.0/100g

Detail
Benzyl 2-bromoethyl ether

A2498411462-37-997%

Benzyl 2-bromoethyl ether

12.0/5g

Detail

A289271583-61-998%

2,3-Dimethylpyridine

19.0/25g

Detail

A30648513965-03-298%

Bis(triphenylphosphine)palladium(II) dichloride

440.0/25g

Detail

A343927455-85-698%

3-Bromo-4-fluorobenzamide

10.0/250mg

Detail
HATU

A633512148893-10-198%

HATU

20.0/25g

Detail